Saturday, 11 July 2020

"Having a dependable kit developed in the country is crucial"- Arunima Patel

01 June 2020 | Views

Arunima Patel, Founder & CEO, iGenetic Diagnostics, Mumbai talks about the company's recent contributions to the COVID-19 fight

Image credit- linkedIn

Image credit- linkedIn

“India has already began testing 1 lakh people a day and our kits will offer a boost to the efforts of ramping up the testing capability further. The RT-PCR test kits have been approved after satisfying the stringent guidelines of ICMR and NIV that squeeze the chances of a false positive or a false negative to zero. These kits are better than global kits in terms of quality, adaptability, and price. Having a dependable kit developed in the country is crucial in these days of restricted movement, when global kits may not be easily available, to cater to the increasing demand, need to scale up production, and can be custom-made to suit the mutation of the virus in the Indian setting. We have partnered with Biogenomics due to their extensive experience and expertise in manufacturing and marketing of biotechnology products, We have already received overwhelming interest and are exploring areas for ramping up,”

-Arunima Patel, Founder & CEO, iGenetic Diagnostics, Mumbai

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account